Patents by Inventor Israel Hanin

Israel Hanin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycosaminoglycans for treatment of emotional dysfunctions
    Patent number: 7812005
    Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (±200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
    Type: Grant
    Filed: May 19, 2004
    Date of Patent: October 12, 2010
    Inventors: Umberto Cornelli, Luigi De Ambrosi, Stanley Lorens, Jawed Fareed, John Lee, Israel Hanin, Ronald Mervis
  • Glycosaminoglycans for treatment of emotional dysfunctions
    Publication number: 20060205690
    Abstract: The present invention relates to the use of glycosaminoglycan fractions having an average molecular weight of 2400 (?200) D for the preparation of pharmaceutical compositions suitable for the treatment of emotional dysfunctions, especially depressive disorders, anxiety disorders, anxiety neurosis, agitation, confusion.
    Type: Application
    Filed: May 19, 2004
    Publication date: September 14, 2006
    Inventors: Umberto Cornelli, Luigi Ambrosi, Stanley Lorens, Jawed Fareed, John Lee, Israel Hanin, Ronald Mervis
  • Glycosaminoglycans having an average molecular weight of 2400 D suitable for the treatment of senile dementia
    Patent number: 6979680
    Abstract: The present invention relates to the use of glycosaminoglycans having an average/molecular weight of 2,400 D for the preparation of pharmaceutical compositions suitable for the treatment of senile dementia, in particular for the treatment of Alzheimer's disease or SDAT (Senile Dementia Alzheimer's Type) and of the cerebral neurological lesions from ictus and from traumas.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: December 27, 2005
    Inventors: Umberto Cornelli, Luigi De Ambrosi, Israel Hanin, Jawed Fareed, John Lee, Stanley Lorens, Ronald F. Mervis
  • Tritium labelled N-mustard type compounds and a process for their production
    Patent number: 4795627
    Abstract: The present invention describes novel tritium labelled nitrogen mustard type compounds, and their aziridinium type analog, and a process for the production of same. The compounds are of value in medical research and development and also as active ingredients of pharmaceutical compositions. The compounds can be used to develop analogs of human disease states and can also be used to evaluate the mechanism of neurotransmitter regulation and function, both in vitro and in vivo.
    Type: Grant
    Filed: October 18, 1984
    Date of Patent: January 3, 1989
    Assignee: University of Pittsburgh
    Inventors: Abraham Fisher, Israel Hanin, Donald J. Abraham